Merck Suspends Zilmax Sales in US & Canada and 2 Other Dow Movers to Watch

Merck & Co. (NYSE:MRK): Current price $47.60

In a Friday statement, Merck said that it will suspend sales of its livestock-feed supplement Zilmax in the United States and in Canada after cattle taking it had difficulties in walking or standing. The suspension is temporary while Merck plans an evaluation of the drug, according to the statement. Merck is making the move after Tyson Foods Inc. said on August 8 that it was halting its use of Zilmax because of lame livestock found at its facilities. Merck’s animal health unit brought in $3.39 billion in 2012. The company sells veterinary and farm products in over 140 countries.


Wal-Mart Stores Inc. (NYSE:WMT): Current price $73.85

Members of the Texas Hearing Aid Association have brought a federal class-action lawsuit against Wal-Mart Stores Inc. that is based upon allegations that the retailer sells hearing aids without a state-mandated license. The group wants to block Wal-Mart’s hearing aid sales at once, along with requesting that the court require the return of profits from prior sales.

Attorney Bill Chamblee, managing partner of Chamblee, Ryan, Kershaw & Anderson, and lead counsel for the hearing aid group, remarked that, “Wal-Mart knew it was required under Texas state law to become licensed in order to dispense hearing aids in Texas stores, yet the corporation has failed to take all necessary steps to ensure their ability to do so.”


AT&T Inc. (NYSE:T): Current price $33.96

On Friday, AT&T said it is searching for applicants for close to 200 positions across Tennessee, including some 100 new jobs. The carrier is hiring full and part-time employees in customer support, retail, and U-verse premise technician positions and plans to start filling these positions immediately.


Don’t Miss: Samsung Pays ITC to Keep Violating Apple Patents.